LGALS3 and cancer: Meanwhile, we found that the plasma LIF or Gal3 levels of tumor-bearing mice were not affected by the exogenous NE treatment (Supplementary information, Fig. S8c), confirming that the release of LIF or Gal3 by cancer cells was independent of sympathetic signaling.